CN1551774A - 紧急避孕药物剂量方案和药物组合物 - Google Patents

紧急避孕药物剂量方案和药物组合物 Download PDF

Info

Publication number
CN1551774A
CN1551774A CNA028137523A CN02813752A CN1551774A CN 1551774 A CN1551774 A CN 1551774A CN A028137523 A CNA028137523 A CN A028137523A CN 02813752 A CN02813752 A CN 02813752A CN 1551774 A CN1551774 A CN 1551774A
Authority
CN
China
Prior art keywords
levonorgestrel
single dose
active component
dose
emergency
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA028137523A
Other languages
English (en)
Chinese (zh)
Inventor
P��F��A����³��
P·F·A·范鲁克
I·巴罗格
K·科曼迪
L·内梅斯
Z·萨伯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Richter Gedeon Vegyeszeti Gyar Nyrt
Original Assignee
Richter Gedeon Vegyeszeti Gyar RT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszeti Gyar RT filed Critical Richter Gedeon Vegyeszeti Gyar RT
Publication of CN1551774A publication Critical patent/CN1551774A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
CNA028137523A 2001-11-27 2002-11-26 紧急避孕药物剂量方案和药物组合物 Pending CN1551774A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU0105173A HU227198B1 (en) 2001-11-27 2001-11-27 Pharmaceutical composition for emergency contraception containing levonorgestrel
HUP0105173 2001-11-27

Publications (1)

Publication Number Publication Date
CN1551774A true CN1551774A (zh) 2004-12-01

Family

ID=89998939

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA028137523A Pending CN1551774A (zh) 2001-11-27 2002-11-26 紧急避孕药物剂量方案和药物组合物

Country Status (33)

Country Link
US (1) US20050288264A2 (https=)
EP (1) EP1448207B1 (https=)
JP (1) JP2005516904A (https=)
KR (1) KR100908161B1 (https=)
CN (1) CN1551774A (https=)
AP (1) AP1849A (https=)
AT (1) ATE293978T1 (https=)
AU (1) AU2002347401A1 (https=)
BR (1) BR0210595A (https=)
CA (1) CA2450359C (https=)
DE (1) DE60203929T2 (https=)
DK (1) DK1448207T3 (https=)
EA (1) EA006545B1 (https=)
EC (1) ECSP045171A (https=)
ES (1) ES2239727T3 (https=)
GE (1) GEP20063882B (https=)
HR (1) HRP20040584B1 (https=)
HU (1) HU227198B1 (https=)
IL (1) IL159394A0 (https=)
IS (1) IS2691B (https=)
MA (1) MA27076A1 (https=)
MX (1) MXPA04005104A (https=)
NO (1) NO333984B1 (https=)
NZ (1) NZ530056A (https=)
OA (1) OA12730A (https=)
PL (1) PL206010B1 (https=)
PT (1) PT1448207E (https=)
RS (1) RS50768B (https=)
SI (1) SI1448207T1 (https=)
TN (1) TNSN04048A1 (https=)
UA (1) UA79942C2 (https=)
WO (1) WO2003045397A1 (https=)
ZA (1) ZA200404114B (https=)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101732324B (zh) * 2009-12-31 2011-12-07 广州朗圣药业有限公司 一种含有左炔诺孕酮的紧急避孕药物组合物及其制备方法
CN110917154A (zh) * 2019-12-12 2020-03-27 上海信谊天平药业有限公司 一种左炔诺孕酮片的制备方法

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008079245A2 (en) * 2006-12-20 2008-07-03 Duramed Pharmaceuticals, Inc. Orally disintegrating solid dosage forms comprising progestin and methods of making and use thereof
BRPI0819571A2 (pt) * 2007-12-20 2019-09-24 Teva Womenss Health Inc "método para contracepção de emergência, pacote farmacêutico para contracepção de emergência e composição farmacêutica"
US8512745B2 (en) 2008-12-08 2013-08-20 Laboratoire Hra Pharma Ulipristal acetate tablets
EP2365811A1 (en) * 2008-12-12 2011-09-21 Laboratoire HRA Pharma A method for contraception
BRPI1014035A2 (pt) 2009-04-14 2016-04-12 Hra Pharma Lab método para contracepção.
CN102458386B (zh) * 2009-06-23 2016-04-06 拜耳知识产权有限责任公司 用于紧急避孕的药物组合物
SG195118A1 (en) 2011-06-01 2013-12-30 Estetra S A Process for the production of estetrol intermediates
PT2714712T (pt) 2011-06-01 2016-11-08 Estetra Sprl Processo para a produção de intermediários de estetrol
EP2383279A1 (en) 2011-07-19 2011-11-02 Pantarhei Bioscience B.V. Process for the preparation of estetrol
PL2741824T3 (pl) * 2011-08-11 2018-03-30 Estetra S.P.R.L. Zastosowanie estetrolu jako środka antykoncepcji awaryjnej
CN104797258A (zh) 2012-11-22 2015-07-22 拜耳药业股份公司 包含左炔诺孕酮和cox抑制剂的药物组合物用于按需避孕的用途和施用方法
EP2999469A1 (de) 2013-05-23 2016-03-30 Bayer Pharma Aktiengesellschaft Pharmazeutische zusammensetzung und deren verwendung sowie anwendungsregime dieser pharmazeutischen zusammensetzung zur bedarfsweisen ( on-demand") kontrazeption
CN103877058A (zh) * 2014-03-26 2014-06-25 邵娜 一种左炔诺孕酮片及其制备工艺
LT3310345T (lt) 2015-06-18 2021-06-25 Estetra Sprl Burnoje disperguojama tabletė, turinti estetrolio
LT3310346T (lt) 2015-06-18 2021-06-10 Estetra Sprl Burnoje disperguojama tabletė, turinti estetrolio
DK3701944T3 (da) 2015-06-18 2022-03-14 Estetra Srl Oro-dispergerbar doseringsenhed indeholdende en estetrolkomponent
CR20180042A (es) 2015-06-18 2018-05-03 Mithra Pharmaceuticals S A Unidad de dosificación orodispersable que contiene un componente estetrol.
KR102712911B1 (ko) 2016-08-05 2024-10-04 에스테트라, 소시에떼 아 레스폰서빌리떼 리미떼 월경통 및 생리통의 관리방법
CN111989105B (zh) 2018-04-19 2024-07-19 埃斯特拉私人有限责任公司 化合物以及它们在缓解绝经相关症状中的用途
TWI801561B (zh) 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 化合物及其用於緩解絕經相關症狀的用途
TWI893101B (zh) 2020-04-16 2025-08-11 比利時商埃斯特拉有限責任公司 具有降低之副作用之避孕組成物
WO2022026901A2 (en) * 2020-07-30 2022-02-03 Acer Therapeutics Inc. Nk antagonists for contraception
CN119523923A (zh) * 2024-11-21 2025-02-28 华中药业股份有限公司 一种左炔诺孕酮片及其制备方法

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101732324B (zh) * 2009-12-31 2011-12-07 广州朗圣药业有限公司 一种含有左炔诺孕酮的紧急避孕药物组合物及其制备方法
CN110917154A (zh) * 2019-12-12 2020-03-27 上海信谊天平药业有限公司 一种左炔诺孕酮片的制备方法

Also Published As

Publication number Publication date
KR100908161B1 (ko) 2009-07-16
BR0210595A (pt) 2004-06-08
DE60203929D1 (de) 2005-06-02
RS50768B (sr) 2010-08-31
PL206010B1 (pl) 2010-06-30
PT1448207E (pt) 2005-08-31
IS2691B (is) 2010-10-15
HUP0105173A2 (hu) 2003-08-28
MXPA04005104A (es) 2004-08-19
CA2450359A1 (en) 2003-06-05
HUP0105173D0 (en) 2002-02-28
EP1448207A1 (en) 2004-08-25
AU2002347401A1 (en) 2003-06-10
US20050288264A2 (en) 2005-12-29
NZ530056A (en) 2005-02-25
ECSP045171A (es) 2004-08-27
DE60203929T2 (de) 2006-01-19
EA200400731A1 (ru) 2004-12-30
JP2005516904A (ja) 2005-06-09
DK1448207T3 (da) 2005-06-27
EP1448207B1 (en) 2005-04-27
RS4204A (sr) 2007-02-05
IS7065A (is) 2003-12-05
CA2450359C (en) 2011-05-10
HU227198B1 (en) 2010-10-28
TNSN04048A1 (en) 2006-06-01
AP2004003046A0 (en) 2004-06-30
WO2003045397A1 (en) 2003-06-05
PL369520A1 (en) 2005-04-18
IL159394A0 (en) 2004-06-01
EA006545B1 (ru) 2006-02-24
ZA200404114B (en) 2005-10-26
HUP0105173A3 (en) 2004-03-29
GEP20063882B (en) 2006-07-25
AP1849A (en) 2008-05-23
UA79942C2 (en) 2007-08-10
ATE293978T1 (de) 2005-05-15
HRP20040584A2 (en) 2005-02-28
ES2239727T3 (es) 2005-10-01
HRP20040584B1 (en) 2012-11-30
SI1448207T1 (en) 2005-10-31
NO333984B1 (no) 2013-11-04
OA12730A (fr) 2006-06-28
MA27076A1 (fr) 2004-12-20
NO20041607L (no) 2004-04-20
US20050032755A1 (en) 2005-02-10
KR20040066088A (ko) 2004-07-23

Similar Documents

Publication Publication Date Title
CN1551774A (zh) 紧急避孕药物剂量方案和药物组合物
RU2542779C2 (ru) Способ контрацепции, используемый по мере необходимости
CN102458386B (zh) 用于紧急避孕的药物组合物
KR20130048227A (ko) 드로스피레논을 포함하는 약학적 조성물 및 피임용 키트
US20190262361A1 (en) Progesterone Receptor Modulators for Use in the Therapy of Uterine Fibroids
HK1070275A (en) Dosage regimen and pharmaceutical composition for emergency contraception
US20260115203A1 (en) Low-dose mifepristone for the treatment of endometriosis associated pain
CN117715644A (zh) 纯孕激素口服避孕
HK40108056A (zh) 纯孕激素口服避孕
HK1170686B (en) Pharmaceutical composition for emergency contraception
HK1168530B (en) Method for on-demand contraception

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1070275

Country of ref document: HK

C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication
REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1070275

Country of ref document: HK